Coologics

Executive Summary

Coologics is a clinical-stage medical device company based in San Diego, California, developing a drug-free solution for vaginal yeast and bacterial infections using patented controlled-cooling technology. Founded in 2015 by a female OB/GYN who personally suffered from recurrent infections, the company's device aims to provide immediate symptom relief and faster treatment without pharmaceuticals. Currently in Phase 1 clinical development, Coologics addresses a large unmet need in women's health, as millions of women experience recurrent vulvovaginal infections. The drug-free approach differentiates it from antifungal and antibiotic therapies, potentially reducing resistance and side effects. While early stage, the company's focus on a safe, non-invasive device with a clear mechanism could attract interest from investors and partners seeking innovations in women's health. Key risks include the need for successful clinical validation and regulatory clearance. Overall, Coologics presents a novel therapeutic alternative in the infectious disease diagnostics and treatment space.

Upcoming Catalysts (preview)

• Q3 2026Completion of Phase 1 Clinical Trial Results60% success
• Q4 2026FDA Breakthrough Device Designation50% success